Dronedarone Hcl
Brand name: Multaq
Rank #132 of 500 drugs by total cost
$123.4M
Total Cost
98,156
Total Claims
$123.4M
Total Cost
3,476
Prescribers
$1,257
Cost per Claim
11,963
Beneficiaries
165,505
30-Day Fills
$35K
Avg Cost/Provider
28
Avg Claims/Provider
About Dronedarone Hcl
Dronedarone Hcl (sold as Multaq) was prescribed 98,156 times by 3,476 Medicare Part D providers in 2023, costing the program $123.4M. At $1,257 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 129 | Tiotropium Br/Olodaterol Hcl (Stiolto Respimat) | $130.3M | 201,233 |
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology